ArticleClinical transplantation and research2026
Correlative study of hepatic venous diameter/liver volume index and extent of hepatic steatosis in living related liver donors: a retrospective observational study.
Article in Clinical transplantation and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hepatic steatosis is a common incidental finding during pretransplant donor evaluation and a key determinant of graft suitability. During review of donor imaging, we observed that hepatic steatosis was frequently associated with smaller hepatic venous diameters. This study aimed to quantitatively assess the relationship between total hepatic venous diameter and hepatic steatosis and to develop a noninvasive predictive index based on hepatic venous diameter and liver volume. Methods: This retrospective study included 768 prospective liver donors who underwent pretransplant evaluation over 3.5 years. Total hepatic venous diameter (THVD) and total liver volume were measured on computed tomography, and hepatic fat content was quantified using magnetic resonance (MR) proton density fat fraction (PDFF) sequences. We analyzed the correlation between the THVD-to-liver volume ratio (THVD/LV) and hepatic steatosis and evaluated diagnostic performance. Results: Hepatic steatosis (MR-PDFF >6.4%) was present in 22% (169/768) of donors; most had a body mass index of 25.0 to 29.9 kg/m Conclusions: The THVD/LV index may serve as a simple, noninvasive parameter for screening hepatic steatosis in living liver donors, given its high NPV. Its application could improve donor-recipient matching and aid preoperative risk assessment for transplant outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.